Volume 5, Issue 12: Non-pulmonary CFTR modification targets

e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 12)


Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe the effects of CFTR modulation on nutritional status
  • Evaluate the observational data supporting the impact of CFTR modulation on chronic infection in CF
  • Summarize the newer advances in our understanding of the pathophysiology of CF and how CFTR modulation may impact this process


Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Registration opens: 
Registration closes: 
Christopher Goss, MD
Division of Pulmonary and Critical Care Medicine
Professor of Pediatrics
University of Washington Medical Center
Seattle, Washington
Dr. Christopher Goss reports that he has research grant funding from Vertex Pharmaceuticals Inc. In addition, he has received honoraria from Gilead Sciences and L. Hoffman–La Roche Ltd.


Unlabeled/Unapproved Uses

Dr. Christopher Goss has reports that the activity will not contain any discussion of off-label or unapproved drugs or products, with the exception of ataluren

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance


Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE